EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development and Validation of a Rapid and Sensitive Lateral Flow Immunoassay for the Detection of SARS‐CoV‐2

Abdenacer Benchrifa, Mounyr Balouiri, Hicham El Hadi, Slimane Farid, Oumaima Lachiri, Meriem Chadli, Youssef Bakri, Abdeladim Moumen

Advances in Virology · 2026-01 · 2026 (1)

DOI: 10.1155/av/5575569 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Virology, online erschienen am 07.02.2026. Verfasst von Abdenacer Benchrifa und 7 weiteren Autor:innen. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Moroccan Foundation for Advanced Science, Innovation and Research, Université Mohammed VI Polytechnique.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The COVID‐19 pandemic caused by SARS‐CoV‐2 has highlighted the need for rapid, cost‐effective, and reliable, locally produced diagnostic tools to respond to, manage, and mitigate the disease or future infectious diseases. This paper reports the development and validation of an antigen‐based lateral flow immunoassay (LFA) for the detection of the SARS‐CoV‐2 virus in nasopharyngeal swabs. The developed test uses gold nanoparticle–conjugated monoclonal antibodies for nucleocapsid detection and monoclonal antibodies immobilized on nitrocellulose membrane for complex capturing and readout. Results showed a limit of detection (LOD) of 20 ng/mL of recombinant nucleocapsid protein. Evaluation using 88 nasopharyngeal swabs showed excellent clinical performance with 87.8% sensitivity (95% CI: 73.8%–95.92%) and 100% specificity (95% CI: 92.45%–100%) compared to RT‐qPCR in a 10‐min readout time. Although further validation with a larger cohort is needed, these results suggest that the developed LFA offers a promising tool for rapid and reliable SARS‐CoV‐2 detection, particularly in resource‐limited settings or for rapid screening.

Förderung

  • Moroccan Foundation for Advanced Science, Innovation and Research
  • Université Mohammed VI Polytechnique

Zitieren

APA

Benchrifa, A., Balouiri, M., Hadi, H. E., Farid, S., Lachiri, O., Chadli, M., Bakri, Y., & Moumen, A. (2026). Development and Validation of a Rapid and Sensitive Lateral Flow Immunoassay for the Detection of SARS‐CoV‐2. Advances in Virology, 2026(1). https://doi.org/10.1155/av/5575569

Vancouver

Benchrifa A, Balouiri M, Hadi HE, Farid S, Lachiri O, Chadli M, et al. Development and Validation of a Rapid and Sensitive Lateral Flow Immunoassay for the Detection of SARS‐CoV‐2. Advances in Virology. 2026;2026(1). doi:10.1155/av/5575569

BibTeX
@article{Benchrifa2026,
  author = {Benchrifa, Abdenacer and Balouiri, Mounyr and Hadi, Hicham El and Farid, Slimane and Lachiri, Oumaima and Chadli, Meriem and Bakri, Youssef and Moumen, Abdeladim},
  title = {Development and Validation of a Rapid and Sensitive Lateral Flow Immunoassay for the Detection of SARS‐CoV‐2},
  journal = {Advances in Virology},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/av/5575569}
}
Kostenlos starten →